| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.HYP.21.3.294 |
| P698 | PubMed publication ID | 8478038 |
| P50 | author | Gaétan Thibault | Q106564320 |
| P2093 | author name string | E L Schiffrin | |
| R Larivière | |||
| P433 | issue | 3 | |
| P304 | page(s) | 294-300 | |
| P577 | publication date | 1993-03-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats | |
| P478 | volume | 21 |
| Q33570102 | Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension |
| Q36674362 | Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists? |
| Q35872696 | Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats |
| Q41220908 | Calcium antagonists and endothelial function: focus on nitric oxide and endothelin |
| Q43894408 | Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. |
| Q70939411 | Cardiac endothelin-1 content and receptor subtype in spontaneously hypertensive rats |
| Q35042395 | Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ET(B) receptor-mediated vascular responses |
| Q74317105 | Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats |
| Q43173570 | Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats |
| Q43690254 | Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats |
| Q74506030 | Effects of endothelin-1 on norepinephrine-induced vasoconstriction in deoxycorticosterone acetate-salt hypertensive rats |
| Q37488978 | Effects of rosiglitazone on heat shock protein and the endothelin system in deoxycorticosterone acetate-salt hypertensive rats |
| Q41349623 | Endothelial dysfunction and hypertension. |
| Q37573188 | Endothelin and the renal microcirculation |
| Q59275528 | Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives |
| Q44601176 | Endothelin-1 Stimulates Arterial VCAM-1 Expression Via NADPH Oxidase-Derived Superoxide in Mineralocorticoid Hypertension |
| Q42581581 | Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium |
| Q43263700 | Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists |
| Q41775299 | Enhanced blood pressure sensitivity to DOCA-salt treatment in endothelin ET(B) receptor-deficient rats |
| Q26746191 | Factors regulating the renal circulation in spontaneously hypertensive rats |
| Q42708365 | Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats |
| Q43142472 | Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats |
| Q77709154 | Impact of endothelin-1 on vascular structure and function |
| Q70939363 | Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat |
| Q42765706 | Influence of periostin-positive cell-specific Klf5 deletion on aortic thickening in DOCA-salt hypertensive mice |
| Q37219178 | Involvement of endothelin-1 in habitual exercise-induced increase in arterial compliance. |
| Q74137884 | Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats |
| Q34702439 | Participation of renal and circulating endothelin in salt-sensitive essential hypertension |
| Q54043197 | Plasma endothelin is increased in early essential hypertension. |
| Q43540653 | Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats |
| Q37358980 | Role of aldosterone in the remnant kidney model in the rat. |
| Q28361188 | Role of endothelin and vasopressin in DOCA-salt hypertension |
| Q42249359 | Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension |
| Q36346910 | Sexual dimorphism in rodent models of hypertension and atherosclerosis |
| Q58656745 | The Endothelins |
| Q41064358 | The clinical potential of endothelin receptor antagonists in cardiovascular medicine. |
| Q72989782 | The effect of an endothelin antagonist on blood pressure in a rat model of preeclampsia |
| Q41290159 | The endothelin system and its potential as a therapeutic target in cardiovascular disease. |
| Q41306104 | The endothelium of resistance arteries: physiology and role in hypertension |
| Q36442583 | The future of endothelin-receptor antagonism as treatment for systemic hypertension |
| Q36012883 | The genetic basis for altered blood vessel function in disease: large artery stiffening |
| Q43612193 | The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus |
| Q64101852 | The renin-angiotensin-aldosterone system and its suppression |
| Q74178147 | Type 2 corticotropin-releasing hormone receptor mRNA expression in the heart in hypertensive rats |
| Q36162950 | Vascular endothelin in hypertension |
| Q46564051 | Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure |
| Q41270143 | Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. |
Search more.